ArticleHealth affairs scholar2025
Opportunities for employers to address the opioid epidemic: results from a national survey.
Article in Health affairs scholar, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Employers play a critical role in addressing the opioid crisis in the United States, so the federal government created the Recovery-Ready Workplace (RRW) framework, which suggests employer action in 4 areas: prevention and risk reduction, education, employment, and treatment. Methods: This study examines employees' views of RRW-related actions taken by their employers to address opioid misuse, using a national survey of 1010 U.S. employees. Results: Results showed significant shortfalls across RRW areas. Only 19% of employees said Narcan was available at work, and only 27% said their employer offered opioid prevention services. Moreover, 79% believed that most coworkers would not be very comfortable receiving opioid abuse prevention information from their employer. Majorities supported retaining co-workers in opioid treatment when they had strong performance records (72%), were monitored (64%), or never misused opioids during work (61%). However, one-third (33%) believed that if employees with good records sought treatment, their employer would be more likely to look for ways to fire rather than support the employee. Conclusion: More employer action is needed, with consideration for expanding Narcan availability, increasing employee access to prevention programs, enhancing employment practices to keep people in the workforce, and cultural shifts to reduce stigma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.